Evidence map›Paper›PMID 41408458›Full record

ArticleBone marrow transplantation2026

Current capacity and gaps in viral vector manufacturing: a survey of centers associated with CTIWP of EBMT, NXTGEN-hightech, DARE-NL, T2EVOLVE, and GoCART coalition.

Ganesh Ramesh, Zsolt Sebestyen, Anil Kumar Deshantri, Simone Punt, Emma Martinez Sanchez, Jesus Fernandez-Sojo, Sergi Querol, Michael Hudecek, Carmen Sanges, Ruud Das and 18 more

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Bone marrow transplantation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Ganesh RameshUniversity Medical Center Utrecht, Utrecht, The Netherlands.ORCID http://orcid.org/0009-0006-8232-6136
Zsolt SebestyenUniversity Medical Center Utrecht, Utrecht, The Netherlands.
Anil Kumar DeshantriUniversity Medical Center Utrecht, Utrecht, The Netherlands.
Simone PuntUniversity Medical Center Utrecht, Utrecht, The Netherlands.
Emma Martinez SanchezUniversity Medical Center Utrecht, Utrecht, The Netherlands.
Jesus Fernandez-SojoServei de Terapia ce·llular, Banc de Sang i Teixits, Barcelona, Spain; Grup de Medicina Transfusional, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.ORCID http://orcid.org/0000-0002-4016-0020
Sergi QuerolSpanish Bone Marrow Registry (REDMO), Barcelona, Spain.
Michael HudecekMedizinische Klinik und Poliklinik II und Lehrstuhl für Zelluläre Immuntherapie, Medizinische Klinik II, Universitätsklinikum Würzburg, Würzburg, Germany.
Carmen SangesFraunhofer-Institut für Zelltherapie und Immunologie (IZI), Außenstelle Zelluläre Immuntherapie, Würzburg, Germany.
Ruud DasScinus Cell Expansion Netherlands BV, Zeist, The Netherlands.
Aiko BallardiniInnovation Center for Advanced Therapies, UMCU, Utrecht, The Netherlands.
Cristina EguizabalAdvanced Therapies Unit, Basque Center for Blood Transfusion and Human Tissues, Galdakao, Spain; Cell Therapy, Stem Cells and Tissues, Biobizkaia Health Research Center, Barakaldo, Spain.
Dirk GeertsDepartment of Hematology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
Ardeshir GhavamzadehMotamed Cancer Institute, Academic Center for Education, Culture and Research, Tehran, Iran.
Virginia Escamilla GómezHospital Universitario Virgen Del Rocío, Seville, Spain.ORCID http://orcid.org/0000-0002-0639-574X
Manel JuanHospital Clínic de Barcelona, Barcelona, Spain.ORCID http://orcid.org/0000-0002-3064-1648
Thomas Stauffer LarsenOdense University Hospital, Odense, Denmark.ORCID http://orcid.org/0000-0002-8418-6708
Petr LesnýInstitute of Hematology and Blood Transfusion, Prague, Czech Republic.ORCID http://orcid.org/0000-0002-4198-5630
Daniel LysákUniversity Hospital Pilsen, Pilsen, Czechia.ORCID http://orcid.org/0000-0001-9391-4247
Mirko MüllerFraunhofer Institute for Cell Therapy and Immunology (IZI), Leipzig, Germany.ORCID http://orcid.org/0009-0001-7713-3798
Unai PerpiñáLaboratory of Stem Cells and Regenerative Medicine, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences; Creatio, Production and Validation Center of Advanced Therapies; and Institute of Neurosciences, University of Barcelona, Barcelona, Spain.
Sofieke de WildeErasmus Medical Center, Rotterdam, The Netherlands.ORCID http://orcid.org/0000-0003-2746-4537
Florent MalardHôpital Saint Antoine, AP-HP, Paris, France.ORCID http://orcid.org/0000-0002-3474-0002
Jorinde HoogenboomOn behalf of Cellular Therapy & Immunobiology Working Party (CTIWP) of EBMT, Leiden, The Netherlands.
Jarl MooyaartOn behalf of Cellular Therapy & Immunobiology Working Party (CTIWP) of EBMT, Leiden, The Netherlands.
Annalisa RuggeriOn behalf of Cellular Therapy & Immunobiology Working Party (CTIWP) of EBMT, Milano, Italy.ORCID http://orcid.org/0000-0002-7261-2765
Trudy StraetemansUniversity Medical Center Utrecht, Utrecht, The Netherlands.
Jurgen KuballUniversity Medical Center Utrecht, Utrecht, The Netherlands. J.H.E.Kuball@umcutrecht.nl.ORCID http://orcid.org/0000-0002-3914-7806

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41408458

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.